MedTrace Logo

Smartphone Sensors to Assess Symptom Relief in Patients With Social Anxiety Disorder Undergoing Treatment

NCT06732999 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-09-08

No results posted yet for this study

Summary

The goal of this study is to examine if a digital behavior-based framework, utilizing the BHQ app, can effectively monitor social anxiety symptoms and evaluate the symptom-reducing impact of attentional training for adults (18-65) with social anxiety disorder (SAD), compared to traditional clinical questionnaires and self-reports.

The main questions it aims to answer are:

1. Can the BHQ app provide a reliable digital measure of social anxiety symptoms?
2. Does GC-MRT significantly reduce symptoms of social anxiety as measured through BHQ app monitoring and standard assessment tools?

Researchers will compare the digital BHQ measurements to traditional clinical assessments to see if the app-based measurements is effective in monitoring symptoms relief.

Participants will:

* Complete an initial clinical interview and self-report questionnaires.
* Engage in a computer-based "free-viewing" task for baseline attention assessment using eye tracking.
* Connect to the BHQ app for continuous monitoring throughout the study.
* Undergo attentional training, GC-MRT.
* Complete weekly SPIN assessments.
* Undergo Final evaluation two weeks post-treatment including repeated clinical interviews, self-reports, and the computer-based task to assess changes in attention patterns and symptom reduction.

Conditions

  • Social Anxiety Disorder (SAD)
  • Attention
  • Smartphones
  • Smartphone Application

Interventions

BEHAVIORAL

Gaze-Contingent Music Reward Therapy (GC-MRT

Gaze-Contingent Music Reward Therapy (GC-MRT) is a treatment method for adults with social anxiety disorder found to be effective in reducing social anxiety in various RCTs. This method includes a computerized cognitive training to redirect threat-related attention patterns.

Sponsors & Collaborators

  • Tel Aviv University

    lead OTHER

Principal Investigators

  • Yair Bar-Haim, Professor · School of Psychological Sciences and Sagol School of Neuroscience, Tel Aviv University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-24
Primary Completion
2025-07-30
Completion
2025-07-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06732999 on ClinicalTrials.gov